Lars Nitschke
Friedrich-Alexander-Universität Erlangen-Nürnberg
H-index: 47
Europe-Germany
Top articles of Lars Nitschke
P12. 08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins
2024/3/1
The role of Siglec-G on B cells in autoimmune disease and leukemia
Seminars in Arthritis and Rheumatism
2024/2/1
Lars Nitschke
H-Index: 26
Structure and Signalling Function of the B-Cell Antigen Receptor and Its Coreceptors
2024/1/1
Lars Nitschke
H-Index: 26
The inhibitory receptor Siglec‐G controls the severity of chronic lymphocytic leukemia
EMBO reports
2023/8/3
Lars Nitschke
H-Index: 26
IL-4 induces CD22 expression to restrain the effector program of self-reactive virtual memory T cells
Research Square
2023/4/6
Epistatic effects of siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus
Frontiers in Immunology
2023/3/8
Lars Nitschke
H-Index: 26
B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia
Haematologica
2022/8/8
Lars Nitschke
H-Index: 26
Hassan Jumaa
H-Index: 35
Targeting Human CD22/Siglec-2 with Dimeric Sialosides as Novel Oligosaccharide Mimetics
Journal of Medicinal Chemistry
2022/7/26
Martin Frank
H-Index: 18
Lars Nitschke
H-Index: 26
Sialic acids on B cells are crucial for their survival and provide protection against apoptosis
Proceedings of the National Academy of Sciences
2022/6/21
Coordinated changes in glycosylation regulate the germinal center through CD22
Cell reports
2022/3/15
Jaesoo Jung
H-Index: 4
Lars Nitschke
H-Index: 26
The inhibitory coreceptor CD22 restores B cell signaling by developmentally regulating Cd45−/− immunodeficient B cells
Science signaling
2022/3/1
Lars Nitschke
H-Index: 26
Human CD22-transgenic, primary murine lymphoma challenges immunotherapies in organ-specific tumor microenvironments
International Journal of Molecular Sciences
2021/9/28
Lars Nitschke
H-Index: 26
Siglec-h-deficient mice show enhanced type I IFN responses, but do not develop autoimmunity after influenza or LCMV infections
Frontiers in Immunology
2021/8/23
Lars Nitschke
H-Index: 26
CD22 controls germinal center B cell receptor signaling, which influences plasma cell and memory B cell output
The Journal of Immunology
2021/8/15
Lars Nitschke
H-Index: 26
Intravital quantification reveals dynamic calcium concentration changes across B cell differentiation stages
Elife
2021/3/22
Frank Kirchhoff
H-Index: 44
Lars Nitschke
H-Index: 26
A CD22–Shp1 phosphatase axis controls integrin β7 display and B cell function in mucosal immunity
Nature immunology
2021/3
The human sialic acid-binding immunoglobulin-like lectin Siglec-9 and its murine homolog Siglec-E control osteoclast activity and bone resorption
Bone
2021/2/1
Siglec-15 on osteoclasts is crucial for bone erosion in serum-transfer arthritis
The Journal of Immunology
2020/11/15
Lars Nitschke
H-Index: 26
Humanized CD22 transgenic mouse model for in vivo analysis of anti‐CD22‐based immunotherapy
European Journal of Immunology
2020/11
Lars Nitschke
H-Index: 26
P03. 20 A murine, myc-driven lymphoma model expressing human CD22 enables testing of targeted therapies and their effects on tumor immune microenvironment
2020/10/1
